Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management
Underreporting tuberculosis (TB) cases can compromise surveillance. We evaluated the contribution of pharmacy data in three different managed-care settings and geographic areas. Persons with more than two anti-TB medications were identified by using pharmacy databases. Active TB was confirmed by usi...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2004-08-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/10/8/03-1075_article |
| _version_ | 1818034025546121216 |
|---|---|
| author | Deborah S. Yokoe Steven W. Coon Rachel Dokholyan Michael C. Iannuzzi Timothy F. Jones Sarah Meredith Marisa Moore Lynelle Phillips Wayne Ray Stephanie Schech Deborah Shatin Richard Platt |
| author_facet | Deborah S. Yokoe Steven W. Coon Rachel Dokholyan Michael C. Iannuzzi Timothy F. Jones Sarah Meredith Marisa Moore Lynelle Phillips Wayne Ray Stephanie Schech Deborah Shatin Richard Platt |
| author_sort | Deborah S. Yokoe |
| collection | DOAJ |
| description | Underreporting tuberculosis (TB) cases can compromise surveillance. We evaluated the contribution of pharmacy data in three different managed-care settings and geographic areas. Persons with more than two anti-TB medications were identified by using pharmacy databases. Active TB was confirmed by using state TB registries, medical record review, or questionnaires from prescribing physicians. We identified 207 active TB cases, including 13 (6%) missed by traditional surveillance. Pharmacy screening identified 80% of persons with TB who had received their medications through health plan–reimbursed sources, but missed those treated solely in public health clinics. The positive predictive value of receiving more than two anti-TB medications was 33%. Pharmacy data also provided useful information about physicians’ management of TB and patients’ adherence to prescribed therapy. Pharmacy data can help public health officials to find TB cases and assess their management in populations that receive care in the private sector. |
| first_indexed | 2024-12-10T06:32:36Z |
| format | Article |
| id | doaj.art-54588fe13a6c43e491cabf95e08ee3f2 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-12-10T06:32:36Z |
| publishDate | 2004-08-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-54588fe13a6c43e491cabf95e08ee3f22022-12-22T01:59:01ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592004-08-011081426143110.3201/eid1008.031075Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient ManagementDeborah S. YokoeSteven W. CoonRachel DokholyanMichael C. IannuzziTimothy F. JonesSarah MeredithMarisa MooreLynelle PhillipsWayne RayStephanie SchechDeborah ShatinRichard PlattUnderreporting tuberculosis (TB) cases can compromise surveillance. We evaluated the contribution of pharmacy data in three different managed-care settings and geographic areas. Persons with more than two anti-TB medications were identified by using pharmacy databases. Active TB was confirmed by using state TB registries, medical record review, or questionnaires from prescribing physicians. We identified 207 active TB cases, including 13 (6%) missed by traditional surveillance. Pharmacy screening identified 80% of persons with TB who had received their medications through health plan–reimbursed sources, but missed those treated solely in public health clinics. The positive predictive value of receiving more than two anti-TB medications was 33%. Pharmacy data also provided useful information about physicians’ management of TB and patients’ adherence to prescribed therapy. Pharmacy data can help public health officials to find TB cases and assess their management in populations that receive care in the private sector.https://wwwnc.cdc.gov/eid/article/10/8/03-1075_articletuberculosisMycobacterium tuberculosispopulation surveillanceprescriptionsdrugpatient compliance |
| spellingShingle | Deborah S. Yokoe Steven W. Coon Rachel Dokholyan Michael C. Iannuzzi Timothy F. Jones Sarah Meredith Marisa Moore Lynelle Phillips Wayne Ray Stephanie Schech Deborah Shatin Richard Platt Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management Emerging Infectious Diseases tuberculosis Mycobacterium tuberculosis population surveillance prescriptions drug patient compliance |
| title | Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management |
| title_full | Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management |
| title_fullStr | Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management |
| title_full_unstemmed | Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management |
| title_short | Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management |
| title_sort | pharmacy data for tuberculosis surveillance and assessment of patient management |
| topic | tuberculosis Mycobacterium tuberculosis population surveillance prescriptions drug patient compliance |
| url | https://wwwnc.cdc.gov/eid/article/10/8/03-1075_article |
| work_keys_str_mv | AT deborahsyokoe pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT stevenwcoon pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT racheldokholyan pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT michaelciannuzzi pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT timothyfjones pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT sarahmeredith pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT marisamoore pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT lynellephillips pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT wayneray pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT stephanieschech pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT deborahshatin pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement AT richardplatt pharmacydatafortuberculosissurveillanceandassessmentofpatientmanagement |